Sophia Genetics(SOPH) Stock Price Today

English
中文繁體
中文简体

Dark
Light

Open Account

Download

US Stock MarketDetailed Quotes

SOPH Sophia Genetics

Watchlist

3.320
+0.060+1.84%

Close Mar 31 16:00 ET

3.480
+0.160+4.82%

Post 20:01 ET

221.88MMarket Cap-3.49P/E (TTM)

Full Hours

5D
Daily
Weekly
Monthly
1Q
1Y

Trade Overview

Unit: --

Capital Trend

IntradayDayWeekMonth

No Data

News

Morgan Stanley Maintains Sophia Genetics(SOPH.US) With Hold Rating, Maintains Target Price $5
Moomoo NewsMar 19 14:31 ET · Ratings
Morgan Stanley Keeps Their Hold Rating on SOPHiA GENETICS (SOPH)
TipRanksMar 19 08:25 ET · Ratings
SOPHiA GENETICS Announces Two Million Patient Cases Analyzed, Marking a New Milestone for Data-Driven Medicine at NVIDIA GTC
PR NewswireMar 18 09:00 ET
BTIG Maintains Sophia Genetics(SOPH.US) With Buy Rating, Maintains Target Price $5
Moomoo NewsMar 12 19:31 ET · Ratings
Blood Cancer Diagnostics Market Analysis Report 2025-2030, With Quest Diagnostics, Illumina, InVivoScribe, Asuragen, Danaher, Sequenta, SkylineDx, Bio-Rad Laboratories, Alercell & Sophia Genetics
Yahoo FinanceMar 10 09:06 ET
BTIG Maintains Sophia Genetics(SOPH.US) With Buy Rating, Cuts Target Price to $5
Moomoo NewsMar 6 03:32 ET · Ratings

Comments

Teddy123

Mar 18 21:02

SOPHiA GENETICS Announces Two Million Patient Cases Analyzed, Marking a New Milestone for Data-Driven Medicine at NVIDIA GTC

$Sophia Genetics (SOPH.US)$
SOPHiA GENETICS Hits Major AI Breakthrough: 2M Patient Genomic Profiles Analyzed Worldwide

Jaguar8

Mar 18 21:02

NEWS

$Sophia Genetics (SOPH.US)$
SOPHiA GENETICS Announces Two Million Patient Cases Analyzed, Marking a New Milestone for Data-Driven Medicine at NVIDIA GTC
Tuesday, 18th March at 9:00 am
BOSTON, MA and ROLLE, Switzerland, March 18, 2025 /PRNewswire/ -- SOPHiA GENETICS (NASDAQ: SOPH), a cloud-native software company and leader in data-driven medicine, has reached a historic milestone: more than two million patients genomic profiles analyzed on the AI-powered analytics Platform SOPHiA DDM™. This ...

Teddy123

Feb 24 17:05

Leading Healthcare Institutions Adopt MSK-ACCESS® for Liquid Biopsy Testing

$Sophia Genetics (SOPH.US)$ $AstraZeneca (AZN.US)$
Global Healthcare Revolution: Elite Hospitals Rush to Implement This Game-Changing Cancer Test

103455307

Jan 28 22:42

$Sophia Genetics (SOPH.US)$ unable to sell??

Trytosaveabit

Jan 28 21:50

update

$Sophia Genetics (SOPH.US)$ SOPHiA GENETICS Launches Comprehensive MRD Tracking Capabilities
PR Newswire· 3 mins ago
The cutting-edge OncoPortal Mutation Tracker add-on module enables precision monitoring of evolving genomic cancer drivers

SOPH Sophia Genetics

Trade Overview

Capital Trend

News

Comments

Market Insights